Perrigo Company PLC
NYSE:PRGO
Perrigo Company PLC
NYSE:PRGO
Price:
29.71 USD
0.58%
Market Closed
Updated:
May 22, 2024
Perrigo Company PLC
Cost of Revenue
|
Perrigo Company PLC
Cost of Revenue Peer Comparison
Comparables:
JAZZ
AVDL
G
GHRS
COPN
OVB
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Perrigo Company PLC
NYSE:PRGO
|
Cost of Revenue
-$2.9B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Cost of Revenue
-$402.4m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-14%
|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Cost of Revenue
-$2.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
30%
|
CAGR 10-Years
-22%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Cost of Revenue
-€39.3m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-7%
|
|
|
Ovoca Bio PLC
LSE:OVB
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Perrigo Company PLC's Cost of Revenue?
Cost of Revenue
-2.9B
USD
-2.9B
USD
Based on the financial report for Mar 30, 2024, Perrigo Company PLC's Cost of Revenue amounts to -2.9B USD.
What is Perrigo Company PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-2%
-2%
Over the last year, the Cost of Revenue growth was 3%. The average annual Cost of Revenue growth rates for Perrigo Company PLC have been -5% over the past three years , and -2% over the past ten years .
You don't have any saved screeners yet
